デフォルト表紙
市場調査レポート
商品コード
1788363

持続可能な医薬品包装の世界市場

Sustainable Pharmaceutical Packaging


出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
持続可能な医薬品包装の世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

持続可能な医薬品包装の世界市場は2030年までに2,533億米ドルに到達

2024年に1,076億米ドルと推定される持続可能な医薬品包装の世界市場は、2024年から2030年にかけてCAGR 15.3%で成長し、2030年には2,533億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるプラスチックは、CAGR17.4%を記録し、分析期間終了時には1,273億米ドルに達すると予想されます。紙・板紙セグメントの成長率は、分析期間中CAGR 11.6%と推定されます。

米国市場は283億米ドル、中国はCAGR14.3%で成長予測

米国の持続可能な医薬品包装市場は、2024年に283億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに390億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは14.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ14.4%と13.0%と予測されています。欧州では、ドイツがCAGR 11.0%で成長すると予測されています。

世界の持続可能な医薬品包装市場- 主要動向と促進要因のまとめ

なぜ製薬業界の包装パラダイムは環境問題への関心が高まっているのか?

製薬業界は、伝統的に無菌性、安全性、規制遵守に重点を置いてきましたが、現在では環境フットプリントへの対応、特にパッケージングに対するプレッシャーが高まっています。世界の医薬品生産量とヘルスケア消費量の増加に伴い、医薬品包装廃棄物の規模は無視できないものとなっています。単回使用プラスチック、アルミ箔、多素材ブリスターパック、リサイクル不可能なラミネートは、医薬品の効能を維持するための標準として長い間使用されてきたが、リサイクルが最も困難な素材のひとつでもあります。消費者の関心の高まり、組織のESGへのコミットメント、環境規制が相まって、製薬メーカーは持続可能な代替品への転換を迫られています。こうした変化は、パッケージがブランド認知の中心的役割を果たす一般用医薬品(OTC)、栄養補助食品、消費者向け医薬品ブランドにおいて特に顕著です。病院やヘルスケアプロバイダーもまた、環境に配慮したパッケージングソリューションを好むよう、調達方針を見直しつつあります。利害関係者の気候に対する意識が高まるにつれ、持続可能性は、評判のためだけでなく、市場参入やコンプライアンスのためにも、重要な差別化要因になりつつあります。製薬業界では、製品の完全性と環境への責任という従来のトレードオフの関係が書き換えられつつあり、包装業界はその両方を実現しなければならなくなっています。

イノベーションは持続可能性と厳しい医薬品コンプライアンス基準のバランスを取ることができるか?

持続可能性と、無菌性、バリア保護、湿度感受性、改ざん防止といった医薬品包装の厳しい基準とのバランスをとることは、歴史的に困難な課題でした。しかし、材料科学の革新とデザイン思考が新たな可能性を引き出しています。生分解性ポリマー、リサイクル可能なモノマテリアル、バイオベース樹脂は、規制要件や性能要件を満たすように設計されています。ポリエチレンやポリプロピレンの構造開発により、保護品質を損なうことなく、リサイクル可能なブリスターパックや一次包装部品の製造が可能になりつつあります。一方、二次的・三次的用途向けの繊維ベースの包装形態は、特にプラスチック製インサート、カートン、シュリンクラップの代替品として台頭してきています。ラベリング技術も進化しており、無溶剤接着剤、水性インク、レーザーマーキングが一般的になりつつあり、より広範な持続可能性基準に合致しています。デジタル・トレーサビリティや偽造防止機能を組み込んだスマート・パッケージング・ソリューションも、過剰なラベリングや冗長なパッケージングの必要性を減らしています。重要なことは、軽量化、モジュール化、リサイクル可能性に重点を置くことで、最初から包装設計に持続可能性が組み込まれていることです。環境への影響を最小限に抑えながら、医薬品レベルの無菌性と安全性を満たす包装システムを設計することで、業界は、性能と持続可能性が実際に共存できることを証明し始めています。

政策と患者の期待は、医薬品包装の決定をどのように形作っているか?

規制の枠組みや進化する患者の期待は、今やあらゆるレベルで医薬品包装の決定を再形成しています。欧州連合(EU)では、EUグリーン・ディールと循環型経済行動計画に関連する法律が、製薬会社に対し、プロダクト・スチュワードシップにおいて包装のリサイクル性、材料開示、ライフサイクル評価を考慮するよう促しています。米国では、FDAとEPAが持続可能なヘルスケア慣行に関する対話を拡大し、カリフォルニア州などの州では医薬品包装を含む拡大生産者責任(EPR)法を強化しています。一方、ISO14001のような世界の自主基準や国連の持続可能な開発目標(SDGs)のガイドラインは、包装の持続可能性のベンチマークに利用されています。患者側では、プラスチック廃棄物やヘルスケアの二酸化炭素排出量に対する意識の高まりにより、嗜好が変化しています。特に自宅での治療、個人用医療機器、OTC医薬品などでは、リサイクル可能で廃棄が容易な包装を求める傾向が強まっています。医薬品ブランドは現在、QRコードや透明性機能を取り入れ、廃棄やリサイクル可能性についてユーザーに啓蒙しており、これは患者の信頼やロイヤルティにもつながっています。病院やヘルスケア機関も同様に持続可能な調達基準を採用しており、製薬会社は包装の全ライフサイクルを見直す必要に迫られています。持続可能性はもはやオプションではなく、B2BとB2Cの両方の製薬エコシステムで期待が高まっています。

持続可能な医薬品包装市場の成長加速の原動力は?

持続可能な医薬品包装市場の成長は、技術の進化、業界の力学、エンドユーザーの影響力、世界の政策の勢いなど、相互に関連するいくつかの要因によって牽引されています。リサイクル可能なバリアフィルム、堆肥化可能なバイオポリマー、低炭素材料における技術の先進化により、環境への影響を抑えながら医薬品の性能基準を満たすパッケージングが可能となっています。個別化医療、在宅ヘルスケア、e-pharmaciesに対する需要の高まりは、ユーザーフレンドリーでコンプライアンスに準拠した、モジュール式で軽量かつ持続可能な包装に対するニーズを加速させています。これと並行して、製薬会社は、ESGフレームワークや機関投資家からの圧力に後押しされる形で、持続可能性の目標を製品開発パイプラインや包装業務と整合させつつあります。製造施設のグリーンビルディング認証、スコープ3排出量追跡、循環型サプライチェーンへの取り組みは、包装の持続可能性を工場現場から消費者の手にまで押し上げています。ヘルスケアプロバイダーや薬局は、持続可能なパッケージングの信頼性に基づいてサプライヤーを選択するようになってきており、多くの場合、ライフサイクルアセスメントや材料認証によって裏付けられています。一方、EPR制度やラベリング義務から炭素開示義務に至るまで、規制の追い風が世界市場全体で採用を強化しています。最後に、調達、コンプライアンス、ブランド戦略に持続可能性の指標を組み込むことで、より環境に配慮した包装のビジネスケースは確固たるものとなり、進化する医薬品業界において重要な成長のテコとなっています。

セグメント

素材(プラスチック、紙・板紙、ガラス、金属)、プロセス(リサイクル可能、再利用可能、生分解性)

調査対象企業の例

  • Amcor plc
  • Ascend Packaging Systems
  • Berry Global Inc.
  • Bormioli Pharma S.p.A.
  • CCL Healthcare
  • Corning Incorporated
  • Crown Holdings, Inc.
  • Drug Plastics
  • DS Smith
  • Gerresheimer AG
  • International Paper Company
  • MM Board & Paper
  • Mondi Group
  • PGP Glass
  • SGD Pharma
  • Sharp Services
  • Smurfit Kappa
  • Sonoco Products Company
  • Syntegon Technology GmbH
  • Tetra Pak
  • West Pharmaceutical Services, Inc.
  • WestRock Company

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入(完成品とOEM)に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価(COGS)の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33107

Global Sustainable Pharmaceutical Packaging Market to Reach US$253.3 Billion by 2030

The global market for Sustainable Pharmaceutical Packaging estimated at US$107.6 Billion in the year 2024, is expected to reach US$253.3 Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Plastics, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$127.3 Billion by the end of the analysis period. Growth in the Paper & Paperboard segment is estimated at 11.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.3 Billion While China is Forecast to Grow at 14.3% CAGR

The Sustainable Pharmaceutical Packaging market in the U.S. is estimated at US$28.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$39.0 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.4% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Sustainable Pharmaceutical Packaging Market - Key Trends & Drivers Summarized

Why Is Pharma’s Packaging Paradigm Under Growing Environmental Scrutiny?

The pharmaceutical industry, traditionally focused on sterility, safety, and regulatory compliance, is now facing growing pressure to address its environmental footprint-particularly when it comes to packaging. With global drug production and healthcare consumption on the rise, the scale of pharmaceutical packaging waste has become difficult to ignore. Single-use plastics, aluminum foils, multi-material blister packs, and non-recyclable laminates have long been the standard for preserving drug efficacy, but they are also among the most challenging materials to recycle. Mounting consumer concern, institutional ESG commitments, and environmental regulations are converging to push pharmaceutical manufacturers toward sustainable alternatives. These changes are particularly evident in over-the-counter (OTC) medications, nutraceuticals, and direct-to-consumer pharma brands, where packaging plays a central role in brand perception. Hospitals and healthcare providers are also revisiting procurement policies to favor eco-conscious packaging solutions. As stakeholders grow more climate-conscious, sustainability is becoming a key differentiator-not just for reputation, but for market access and compliance. Pharma’s traditional trade-off between product integrity and environmental responsibility is being rewritten, and the packaging industry must now deliver both.

Can Innovation Balance Sustainability with Stringent Pharma Compliance Standards?

Balancing sustainability with the rigorous standards of pharmaceutical packaging-such as sterility, barrier protection, moisture sensitivity, and tamper evidence-has historically been a formidable challenge. However, material science innovations and design thinking are unlocking new opportunities. Biodegradable polymers, recyclable mono-materials, and bio-based resins are being engineered to meet regulatory and performance requirements. Developments in polyethylene and polypropylene structures are allowing the creation of recyclable blister packs and primary packaging components without compromising protective qualities. Meanwhile, fiber-based packaging formats for secondary and tertiary uses are gaining ground, especially as alternatives to plastic inserts, cartons, and shrink wraps. Labeling technologies are also evolving-solvent-free adhesives, water-based inks, and laser marking are becoming more common, aligning with broader sustainability standards. Smart packaging solutions incorporating digital traceability and anti-counterfeiting features are also reducing the need for excessive labeling and redundant packaging. Importantly, sustainability is being built into packaging design from the start, with increased focus on lightweighting, modularity, and recyclability. By designing packaging systems that meet pharma-grade sterility and safety while minimizing environmental impact, the industry is beginning to prove that performance and sustainability can, in fact, coexist.

How Are Policies and Patient Expectations Reshaping Pharma Packaging Decisions?

Regulatory frameworks and evolving patient expectations are now reshaping pharmaceutical packaging decisions at every level. In the European Union, legislation tied to the EU Green Deal and Circular Economy Action Plan is pushing pharmaceutical companies to consider packaging recyclability, materials disclosure, and lifecycle assessments in their product stewardship. In the United States, the FDA and EPA are expanding dialogue around sustainable healthcare practices, while states like California are tightening extended producer responsibility (EPR) laws that include pharmaceutical packaging. Meanwhile, global voluntary standards such as ISO 14001 and guidelines from the United Nations Sustainable Development Goals (SDGs) are being used to benchmark packaging sustainability. On the patient side, growing awareness of plastic waste and healthcare’s carbon footprint is shifting preferences. Individuals increasingly expect recyclable, easy-to-dispose-of packaging-especially for at-home treatments, personal medical devices, and OTC drugs. Pharmaceutical brands are now incorporating QR codes and transparency features to educate users about disposal and recyclability, which also supports patient trust and loyalty. Hospitals and healthcare institutions are similarly adopting sustainable procurement criteria, prompting pharmaceutical companies to rethink the full lifecycle of their packaging. Sustainability is no longer an optional add-on-it is a growing expectation in both B2B and B2C pharma ecosystems.

What’s Driving the Accelerated Growth of the Sustainable Pharmaceutical Packaging Market?

The growth in the sustainable pharmaceutical packaging market is driven by several interconnected factors related to technology evolution, industry dynamics, end-user influence, and global policy momentum. Technological advances in recyclable barrier films, compostable biopolymers, and low-carbon materials are enabling packaging to meet pharmaceutical performance standards while reducing environmental impact. The rising demand for personalized medicine, home healthcare, and e-pharmacies is accelerating the need for modular, lightweight, and sustainable packaging that is user-friendly and compliant. In parallel, pharmaceutical companies are aligning sustainability goals with product development pipelines and packaging operations, often driven by ESG frameworks and pressure from institutional investors. Green building certifications for manufacturing facilities, Scope 3 emissions tracking, and circular supply chain initiatives are pushing packaging sustainability from the factory floor to the consumer's hands. Healthcare providers and pharmacies are increasingly selecting suppliers based on sustainable packaging credentials, often supported by lifecycle assessments and material certifications. Meanwhile, regulatory tailwinds-from EPR schemes and labeling mandates to carbon disclosure requirements-are reinforcing adoption across global markets. Finally, the integration of sustainability metrics into procurement, compliance, and brand strategy is solidifying the business case for greener packaging, making it a critical growth lever in the evolving pharmaceutical landscape.

SCOPE OF STUDY:

The report analyzes the Sustainable Pharmaceutical Packaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Plastics, Paper & Paperboard, Glass, Metal); Process (Recyclable, Reusable, Biodegradable)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Amcor plc
  • Ascend Packaging Systems
  • Berry Global Inc.
  • Bormioli Pharma S.p.A.
  • CCL Healthcare
  • Corning Incorporated
  • Crown Holdings, Inc.
  • Drug Plastics
  • DS Smith
  • Gerresheimer AG
  • International Paper Company
  • MM Board & Paper
  • Mondi Group
  • PGP Glass
  • SGD Pharma
  • Sharp Services
  • Smurfit Kappa
  • Sonoco Products Company
  • Syntegon Technology GmbH
  • Tetra Pak
  • West Pharmaceutical Services, Inc.
  • WestRock Company

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sustainable Pharmaceutical Packaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Regulatory Pressure on Plastic Waste Reduction Throws the Spotlight on Sustainable Pharmaceutical Packaging
    • Pharma Industry's Shift Toward ESG-Aligned Operations Drives Demand for Eco-Conscious Packaging Solutions
    • Growing Global Scrutiny on Single-Use Plastics Strengthens the Business Case for Recyclable and Compostable Materials
    • Here's How Circular Packaging Models Expand the Addressable Market for Refillable and Reusable Pharma Packs
    • Demand for Green Labelling and Compliance Transparency Spurs Innovation in Sustainable Packaging Formats
    • Increased Focus on Carbon Footprinting and Scope 3 Emissions Accelerates Adoption of Low-Impact Packaging
    • Emergence of Bio-Based Polymers and Smart Barrier Technologies Propel Growth in Eco-Friendly Primary Packaging
    • Here's the Story: How Patient-Centric Sustainability Preferences Drive Market Acceptance of Green Packaging Designs
    • Advanced Sterilization Compatibility and Regulatory Certifications Drive Adoption of Sustainable Alternatives
    • Pharmaceutical Cold Chain Expansion Generates Demand for Recyclable and Insulated Green Packaging
    • Waste Management Regulations in Emerging Markets Generate Opportunities for Localized Sustainable Packaging Solutions
    • Lifecycle Assessment Tools and Digital Traceability Standards Strengthen the Business Case for Packaging Optimization
    • Blister Pack Redesign and Lightweighting Initiatives Sustain Growth in Material-Efficient Pharma Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sustainable Pharmaceutical Packaging Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sustainable Pharmaceutical Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sustainable Pharmaceutical Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Plastics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Plastics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Plastics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Paper & Paperboard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Paper & Paperboard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Paper & Paperboard by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Glass by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Glass by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Glass by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Recyclable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Recyclable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Recyclable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Reusable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Reusable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Reusable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • JAPAN
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • CHINA
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • EUROPE
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Sustainable Pharmaceutical Packaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Sustainable Pharmaceutical Packaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • FRANCE
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • GERMANY
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sustainable Pharmaceutical Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Sustainable Pharmaceutical Packaging by Material - Plastics, Paper & Paperboard, Glass and Metal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Sustainable Pharmaceutical Packaging by Material - Percentage Breakdown of Value Sales for Plastics, Paper & Paperboard, Glass and Metal for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Sustainable Pharmaceutical Packaging by Process - Recyclable, Reusable and Biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Sustainable Pharmaceutical Packaging by Process - Percentage Breakdown of Value Sales for Recyclable, Reusable and Biodegradable for the Years 2015, 2025 & 2030

IV. COMPETITION